C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C-Myc inhibition intensified the anti-leukemic properties of Imatinib in chronic myeloid leukemia cells
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-04
DOI
10.1007/s11033-023-08832-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
- (2022) Si-Xia Wu et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
- (2022) Govinda Poudel et al. Cancers
- MEK inhibitors for the treatment of non-small cell lung cancer
- (2021) Jing Han et al. Journal of Hematology & Oncology
- Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
- (2021) Sarah K. Madden et al. Molecular Cancer
- Abrogation of histone deacetylases (HDACs) decreases survival of chronic myeloid leukemia cells: New insight into attenuating effects of the PI3K/c‐Myc axis on panobinostat cytotoxicity
- (2021) Sara Zehtabcheh et al. CELL BIOLOGY INTERNATIONAL
- Autophagy-related signaling pathways are involved in cancer (Review)
- (2021) Caixia Chen et al. Experimental and Therapeutic Medicine
- The long journey to bring a Myc inhibitor to the clinic
- (2021) Jonathan R. Whitfield et al. JOURNAL OF CELL BIOLOGY
- Epigenetic Silencing of MYC By Proteasome Inhibitors
- (2021) Andre Catic et al. BLOOD
- Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes
- (2021) Roya Ghaffarnia et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
- (2021) Raquel Alves et al. Cancers
- Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: an emerging approach to overcome MSC-induced resistance
- (2020) Mohammad Mosleh et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting autophagy to overcome drug resistance: further developments
- (2020) Haocai Chang et al. Journal of Hematology & Oncology
- Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
- (2020) Simona Soverini et al. Journal of Clinical Medicine
- MYC Oncogene Contributions to Release of Cell Cycle Brakes
- (2019) Lucía García-Gutiérrez et al. Genes
- Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells
- (2019) Negar Sheikh‐Zeineddini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat
- (2019) Ida Annunziata et al. Nature Communications
- Proteasome inhibition in multiple myeloma: lessons for other cancers
- (2019) Paula Saavedra-García et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
- (2016) Sheela A. Abraham et al. NATURE
- Small-molecule inhibitors of the Myc oncoprotein
- (2015) Steven Fletcher et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
- (2015) Meng Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts
- (2015) Q Li et al. CANCER GENE THERAPY
- Concurrent inhibition of MYC and BCL2 is a potentially effective treatment strategy for double hit and triple hit B-cell lymphomas
- (2015) Munevver Cinar et al. LEUKEMIA RESEARCH
- MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
- (2015) Toril Holien et al. Oncotarget
- NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression
- (2015) Haishan Huang et al. Oncotarget
- Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells
- (2014) Jiandong Wang et al. Journal of Translational Medicine
- Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors
- (2014) Inga Müller et al. PLoS One
- Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
- (2014) ITASU NINOMIYA et al. Oncology Letters
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- Myc inhibition impairs autophagosome formation
- (2013) Pearl P. C. Toh et al. HUMAN MOLECULAR GENETICS
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- GADD45 Proteins: Central Players in Tumorigenesis
- (2012) R. E. Tamura et al. CURRENT MOLECULAR MEDICINE
- Phosphoinositide 3-kinase/AKT/mTORC1/2 Signaling Determines Sensitivity of Burkitt's Lymphoma Cells to BH3 mimetics
- (2012) L. C. Spender et al. MOLECULAR CANCER RESEARCH
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MYC in Chronic Myeloid Leukemia: Induction of Aberrant DNA Synthesis and Association with Poor Response to Imatinib
- (2011) M. Albajar et al. MOLECULAR CANCER RESEARCH
- Chronic Myeloid Leukemia: A Historical Perspective
- (2010) John M. Goldman SEMINARS IN HEMATOLOGY
- Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
- (2009) Zheng Hu et al. PLoS One
- Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
- (2008) Jianxia Guo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- FOXOs, cancer and regulation of apoptosis
- (2008) Z Fu et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started